Cellectar Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details 1) - shares	9 Months Ended	12 Months Ended
STOCKHOLDERS' EQUITY (Details 1) - shares	Sep. 30, 2017	Dec. 31, 2016
Number Of Shares Reserved For Future Issuance	9,661,098	12,321,724
Preferred Stock [Member]
Number Of Shares Reserved For Future Issuance	0	1,133,339
Warrant [Member]
Number Of Shares Reserved For Future Issuance	8,726,536	10,716,952
Stock options [Member]
Number Of Shares Reserved For Future Issuance	934,562	471,433